CSS »

Astria Therapeutics shares owned by CSS

Quarter-by-quarter ownership of Astria Therapeutics shares owned by CSS from 13F filings

Historical chart of CSS investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by CSS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by CSS

Quarter filed Position value Share count Share price at filing
2025-12-31 $883k 67k 13.09

More positions owned by CSS

Echostar Corp Note 3.875%11/3 (Principal)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Jazz Investments I Note 2.000% 6/1 (Principal)
Ionis Pharmaceuticals Note 4/0 (Principal)
Western Digital Corp Put Put Option
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Equinox Gold Corp Note 4.750%10/1 (Principal)
Strategy Cl A New Call Option (MSTR)
Lumentum Hldgs Note 1.500%12/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Bridgebio Pharma Note 2.250% 2/0 (Principal)
Bank America Corp 7.25%CNV PFD L (BAC.PL)
Gamestop Corp Cl A (GME)

View all positions for CSS

Top funds holding Astria Therapeutics

Perceptive Advisors
FMR
BlackRock
Glazer Capital
Millennium Management
Vanguard Group
UBS Group
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Driehaus Capital Management
Geode Capital Management
Nantahala Capital Management
Qube Research & Technologies
Omni Event Management
Man Group

View all funds holding Astria Therapeutics